The therapeutic approach of organophosphorus compound (OP) intoxications is to reactivate the inhibited enzyme acetylcholinesterase (AChE). Numerous studies demonstrated a limited efficacy of standard oxime-based reactivators against different nerve agents such as tabun and cyclosarin. This emphasizes research for more effective oximes. In the present study, reactivation kinetics of tabun-, sarin-, cyclosarin-, VX-or paraoxon-ethyl-inhibited human AChE (hAChE) with a homologous series of bis-ortho-pyridiniumaldoximes, Ortho-4 -Ortho-9, was investigated with a robot-assisted setting, allowing determination of second-order reactivation rate constants as well as model calculations. The reactivation constants of Ortho-4 -Ortho-9 resulted in marked differences of affinity and reactivity depending on the OP structure and the linker length of the oximes. In general, the K D values decreased with increasing linker length.
Kinetic analysis of interactions between alkylene-linked bis-pyridiniumaldoximes and human acetylcholinesterases inhibited by various organophosphorus compounds
Timo
INTRODUCTION
Organophosphorus compounds (OP) have been used as insecticides for pest control [1] and as chemical weapons (tabun, sarin, VX) in military conflicts and in terrorist attacks [2;3] . The main mechanism of action of OP is a progressive inhibition of acetylcholinesterase (AChE) by phosphylation (denotes phosphorylation and phosphonylation) of its catalytic serine hydroxyl group leading to an inactive enzyme species [4] . The inability of inhibited AChE to hydrolyze the neurotransmitter acetylcholine results in an endogenous acetylcholine overflow followed by an over-stimulation of cholinergic receptors, a massive disturbance of numerous body functions, and finally in death by respiratory failure [5] . The causal therapeutic approach of OP intoxications is to use oximes as nucleophiles to remove the phosphyl moiety and to reactivate the enzyme. Numerous in vitro and in vivo studies demonstrated a limited efficacy of standard reactivators against different OP [6] . One particular challenge is the reactivation of tabun-inhibited AChE, which typically has a secondorder reactivation constant that is several orders of magnitude lower than those of other OP-inhibited AChE, e.g., sarin-inhibited AChE. This fact emphasizes the necessity to search for more effective oximes.
Recently, a homologous series of bis-ortho-pyridiniumaldoximes tethered with 4-9 methylene groups, designated as Ortho-4 -Ortho-9, has been reported as AChE reactivators with the objective of increasing the affinity to phosphorylated human AChE (hAChE), accelerating enzyme dephosphorylation, reducing the therapeutic dosage in order to minimize adverse effects and gaining the ability to counteract a broader range of OP [7] . It was shown, that with an increasing A c c e p t e d M a n u s c r i p t 7
Preparation of OP-inhibited hAChE
Ghosts were incubated with a small volume (1%, v/v) of appropriate OP concentrations ( Fig. 1) for 30 min at 37°C to achieve an AChE inhibition by >95%. Thereafter, the treated samples were dialyzed (phosphate buffer, 0.1 M, pH 7.4) overnight at 4°C to remove residual inhibitor. Then, the absence of inhibitory activity was tested by incubation of treated and control ghosts (30 min, 37 °C).
Reactivation kinetics
Reactivation kinetics was conducted according to Worek et al. [10] . The liquid handling steps of the reactivation tests were done with a Tecan Freedom EVO, for details see [11] . Tests with this robot-assisted setting were done to allow high reproducibility and ensure minimal error probability. In brief, the time-and concentration-dependent reactivation of OP-inhibited hAChE by oximes was tested with Ortho-4 -Ortho-9 (1 -100 µM, 37°C; Fig. 1 
Secondary calculations
In addition, the ratio between the inhibition constant towards native hAChE, K I (data taken from [7] ), and the calculated K D and k r2 was formed. Hereby, the respective constants of Ortho-5 -Ortho-9 were referred to Ortho-4 constants (defined as 1) and the relative ratios between K I and K D or k r2 were calculated.
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Model calculations
The reactivation rate constants of Ortho-4 -Ortho-9 and obidoxime were used to calculate the time-dependent reactivations of GA-, GB-, VX-, and PXEinhibited hAChE (Eq. 3):
(with A t hAChE activity at time t, A 0 control hAChE activity, k obs first-order rate constant of reactivation).
The oxime concentration for the calculation was 50% of K i for Ortho-4 -Ortho-9
and 10 µM for obidoxime [12;13] .
Data export and statistics
The raw data were transferred automatically via macros into Excel files and the constants and percentage of hAChE inhibition were determined with Prism 5.0 (GraphPad Software, San Diego, CA). All data are means of n = 4 experiments.
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RESULTS
Reversible inhibition of hAChE by Ortho-N
It has been shown that reversible inhibition of native hAChE by Ortho-4 -Ortho-9 is related to the length of the linker, i.e., K I decreases from 32 μM (Ortho-4) to 0.3 μM (Ortho-9) [7] . In this study, the reactivation of OP-inhibited hAChE by
Ortho-N was determined with an oxime concentration of 1 -100 μM followed by extensive dilution for assaying hAChE activity. Accordingly, the final oxime concentrations during activity measurements were between 0.00385 and 0.385
μM. Under these conditions, Ortho-4 -Ortho-6 did not affect the control hAChE activity. On the other hand, Ortho-7 (at 0.385 μM) reduced the activity to 76%, and Ortho-8 reduced the activity to 89% and 44% at concentrations of 0.0385 μM and 0.385 μM, respectively. With Ortho-9 the hAChE activity was inhibited to 64% and 15% at assay concentrations of 0.0385 μM and 0.385 μM, respectively.
Reactivation kinetics of Ortho-N
The determination of reactivation rate constants of Ortho-4 -Ortho-9 with hAChE inhibited by a number of structurally different OP ( Fig. 1 ) resulted in marked differences of affinity ( Fig. 2) and reactivity (Fig. 3) . The dissociation constant progressively decreased with increasing linker length. For example, the K D for VX-hAChE showed a 335-fold decrease when the linker length was increased from n = 4 to n = 9 and reached a nanomolar level with Ortho-9 (Fig.   2) . Noteworthy, the differences in K D between different OP conjugates at any 11 given linker length are relatively small.
The ability of oximes to remove the phosphyl residue from the active site of the enzyme, reflected by the reactivity rate constant k r , showed marked differences among the tested OP (Fig. 3) . Reactivity increased from Ortho-4 to Ortho-6 for PXE-and VX-inhibited hAChE and from Ortho-4 to Ortho-7 for GA-inhibited hAChE and decreased again with Ortho-8 and Ortho-9. In contrast, k r decreased with increasing linker length for GB-and GF-inhibited hAChE. The highest k r , 0.515 min -1 , was determined with Ortho-6 and PXE-inhibited hAChE and the largest difference in reactivity among the Ortho-N series was recorded with VX-inhibited hAChE (38.6-fold). Plotting the k r of VX and PXE related to the linker length resulted in similar formed bell-shaped curves, whereas reactivation per se was higher for PXE.
The second-order reactivation rate constant k r2 is the ratio of reactivity and affinity and is reflecting the reactivating efficiency of oximes. In view of the pronounced decrease of K D from Ortho-4 to Ortho-9 the k r2 values increased with all tested OP (Fig. 4) . The range of k r2 values was between 0.093 mM 
Interaction of Ortho-N with native and OP-inhibited hAChE
Ortho-N exhibited a positive relationship between affinity towards native or OPinhibited hAChE and linker length. Hence, it was tempting to form the ratio of K I / K D and Fig. 5 shows that in almost all cases the ratio was > 1, i.e., the affinity of Ortho-N to native hAChE was higher than the one to OP-inhibited enzyme.
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Model calculations
In view of the relationship shown in Figs. 5 and 6, it was compelling to calculate the time-dependent reactivation of Ortho-N at concentrations determined by the respective K I . Concentrations used in these calculations were half of the K i for the respective Ortho-N and 10 μM for obidoxime. The data demonstrate that, under these conditions, the Ortho oximes would result in a slower reactivation of GB-, PXE-and VX-inhibited hAChE compared to obidoxime (10 μM; Fig. 7 ).
Ortho-6 -Ortho-9 would be superior to obidoxime in reactivating GA-inhibited hAChE but still would achieve only partial reactivation within a reasonable time frame.
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DISCUSSION
Reactivation kinetics of OP-inhibited hAChE by Ortho-N
The determination of the reactivation rate constants of Ortho-N revealed a relationship between linker length and affinity to hAChE inhibited by tabun (GA), sarin (GB), cyclosarin (GF), VX and paraoxon-ethyl (PXE; Fig. 2 ). These results are in agreement with previous findings on a continuous decrease of K D from
Ortho-3 to Ortho-9 with echothiophate-inhibited hAChE [7] . pyridinium oximes (obidoxime, HLö-7, HI-6, methoxime) [7;14] . For these clinically used oximes, huge differences in affinity were observed, e.g., a more than 30-or 100-fold difference in K D of obidoxime or 2-PAM between cyclosarin-and sarin-inhibited hAChE, respectively. The high and uniform affinity of Ortho-oximes indicates that the binding site for this series of reactivators is compatible, on the structural level, with GA-, GB-, PXE-and VXinhibited hAChE. This conclusion is in agreement with crystallographic studies of Ortho-7, which suggested that the interaction with the peripheral anionic site 14 in combination with a significant flexibility of the central linker are key factors in the ability of Ortho-7 to reactivate tabun-inhibited AChE [7;14] .
The reactivity of Ortho-N with OP-inhibited hAChE was rather low compared to other oximes (Fig. 3) . The only exception was the reactivation of PXE-inhibited hAChE by Ortho-6 whose k r was higher than the k r values determined with methoxime, HLö 7, HI 6 and 2-PAM, although it did not reach the value of obidoxime (0.81 min -1
) [10] . In contrast to the dissociation constant, the reactivity of Ortho-N was not related to the linker length. With PXE-, VX-and GA-inhibited hAChE, a bell-shaped curve of k r values was observed; while, with GB-and GF-inhibited hAChE, a gradual decrease in reactivity with increasing linker length was found. The overall reactivating efficiency of oximes is determined by the ratio of k r / K D [10] . Predominantly due to the decrease of K D the second-order reactivation constant k r2 increased with the linker length (Fig.   4) . The difference between Ortho-9 and Ortho-4 was moderate with GB-and GF-inhibited hAChE but with GA-inhibited hAChE a more than 400-fold difference was observed. In comparison to obidoxime, 2-PAM, HLö 7, HI 6 and methoxime [15] the Ortho-N exhibited a comparable or even superior reactivating efficiency. In fact, Ortho-6 had a 10-fold and Ortho-9 a 90-fold higher k r2 than obidoxime which is considered to be one of the most effective reactivators of GA-inhibited hAChE [15] . These findings are in agreement with studies of Ortho-7, which showed a significantly higher reactivation activity than both obidoxime and HLö 7 on GA-inhibited AChE [14;16] , and contradict the long standing paradigm that a para-substituted pyridiniumoxime is required for efficient reactivation of GA [17] . The underlying mechanism of the high 15 reactivating efficiency of Ortho oximes with GA-inhibited AChE may be related to a differential binding in the peripheral binding site and a favourable orientation in the active-site gorge of the enzyme [14] .
Relation between intrinsic inhibitory potency and reactivation efficiency
The therapeutic value of oximes in OP poisoning is determined by (a) the reactivating efficiency (k r2 ) with hAChE inhibited by a specific OP, (b) the pharmacokinetics, predicting the course of therapeutic oxime concentrations and thus determining the interval of oxime administration, (c) the intrinsic inhibitory activity of oximes towards native hAChE and (d) the tolerability.
Reversible inhibition of AChE by oximes is dependent on the oxime structure and is a determinant of adverse effects and toxicity [15; 18;19] .
Previously, the inhibitory potency of Ortho oximes was determined with hAChE [7] and it was shown that the affinity increased more than 100-fold from Ortho-4
to Ortho-9 and the inhibition constant K I was only 0.3 μM with Ortho-9. These results are in line with results reported by Patocka and Bielavsky, showing a relationship between the chain length of dimeric para-oximes and the reversible inhibition [20] . Hence, the Ortho-N series is characterized by a positive relationship between affinity towards native or OP-inhibited hAChE and the linker length. It is therefore desirable to determine whether the increase in affinity towards OP-inhibited hAChE may be outweighed by an increase in intrinsic inhibitory potency towards the native enzyme. By forming the ratio K I / K D , it became evident that, with few exceptions, the increase of affinity towards native hAChE was higher than the increase of affinity towards OP-inhibited A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 16 hAChE, i.e., a ratio > 1 (Fig. 5) . In addition, the ratio of K I / k r2 demonstrates that, with GB-, GF-, VX-and PXE-inhibited hAChE, the linker length related improvement of reactivating efficiency is outweighed by increased intrinsic inhibition (Fig. 6 ). These findings underscore the importance of improving reactivation efficiency by increasing mobility of the reactive oxime moiety as reported by Ekström et al. [21] .
Therapeutic use of Ortho oximes
As a consequence of the K I / K D ratio > 1, the therapeutic concentration of the Ortho-N in vivo will be substantially lower compared to the clinically used oximes (2-PAM, obidoxime, HI 6, methoxime). It has been reported that 1 μmol/kg Ortho-7 was well tolerated in rats while 3 μmol/kg killed four of six animals [22] . Due to the high in vivo toxicity of Ortho-7 this oxime was administered at a dose of 1 μmol/kg to echothiophate-poisoned rats resulting in less protection compared to 2-PAM (100 μmol/kg).
The impact of a potentially limited concentration of Ortho-N on the timedependent reactivation was calculated by using the determined reactivation rate constants, therapeutic concentration of obidoxime (10 μM) and concentration of
Ortho-N at half of its K I value [7] . These model calculations (Fig. 7) indicate that, due to the low concentration and subsequent low reactivity of Ortho-N, the reactivation would be markedly slower compared to obidoxime with GB-, VXand PXE-inhibited hAChE. In contrast, the high reactivating efficiency of Ortho-6 -Ortho-9 for GA-inhibited hAChE would result in a superior reactivation relative to obidoxime (10 μM). On the basis of these results, it is worthy of pursuing 17 pharmacokinetic studies and reactivation studies using GA-poisoned animals to properly assess the therapeutic value of Ortho-N in treating GA poisoning.
Conclusions
The reactivation kinetics of Ortho-N with hAChE inhibited by different OP is characterized by an increasing affinity proportional to the linker length, a low to moderate reactivity, and a continuous increase of reactivating efficiency from
Ortho-4 to Ortho-9. At any given linker length, the difference in K D between this collection of OP is comparatively small. The concomitant increase of the affinity of Ortho-4 to Ortho-9 towards native hAChE resulted in a disadvantageous ratio between intrinsic inhibition and reactivating efficiency with GB-, GF-VX-and PXE-inhibited hAChE. However, Ortho-6 -Ortho-9 showed an outstanding reactivating efficiency with GA-inhibited hAChE being up to two orders of magnitude higher compared to obidoxime. Due to the inhibitory potency towards native hAChE, the therapeutic concentration of the most effective Ortho-N will be limited and future in vivo studies are needed to assess the therapeutic value of these oximes in treating GA poisoning. Finally, these kinetic data emphasize the need to develop oximes with a more selective affinity towards OP-inhibited AChE and higher mobility for better reactivation efficiency, to minimize the adverse side effects caused by the reversible inhibition of AChE by oximes. A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Ortho-4 and the ratio of K I / k r2 was formed with these relative constants.
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